Detalles de la búsqueda
1.
Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells.
J Immunol
; 197(12): 4829-4837, 2016 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27807190
2.
Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange.
Proc Natl Acad Sci U S A
; 110(13): 5145-50, 2013 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-23479652
3.
Staphylococcus aureus formyl peptide receptor-like 1 inhibitor (FLIPr) and its homologue FLIPr-like are potent FcγR antagonists that inhibit IgG-mediated effector functions.
J Immunol
; 191(1): 353-62, 2013 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23740955
4.
Mimicking an induced self phenotype by coating lymphomas with the NKp30 ligand B7-H6 promotes NK cell cytotoxicity.
J Immunol
; 189(10): 5037-46, 2012 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23066150
5.
Enhanced FcαRI-mediated neutrophil migration towards tumour colonies in the presence of endothelial cells.
Eur J Immunol
; 42(7): 1815-21, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22535639
6.
Functional characteristics of the high affinity IgG receptor, FcγRI.
J Immunol
; 186(5): 2699-704, 2011 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21325219
7.
Recombinant dimeric IgA antibodies against the epidermal growth factor receptor mediate effective tumor cell killing.
J Immunol
; 186(6): 3770-8, 2011 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21317397
8.
Loss of CD20 and bound CD20 antibody from opsonized B cells occurs more rapidly because of trogocytosis mediated by Fc receptor-expressing effector cells than direct internalization by the B cells.
J Immunol
; 187(6): 3438-47, 2011 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21841127
9.
Epidermal growth factor receptor (EGFR) antibody-induced antibody-dependent cellular cytotoxicity plays a prominent role in inhibiting tumorigenesis, even of tumor cells insensitive to EGFR signaling inhibition.
J Immunol
; 187(6): 3383-90, 2011 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21832160
10.
Species-specific determinants in the IgG CH3 domain enable Fab-arm exchange by affecting the noncovalent CH3-CH3 interaction strength.
J Immunol
; 187(6): 3238-46, 2011 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21841137
11.
Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.
J Immunol
; 186(3): 1840-8, 2011 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21187443
12.
Penetration of antibody-opsonized cells by the membrane attack complex of complement promotes Ca(2+) influx and induces streamers.
Eur J Immunol
; 41(8): 2436-46, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21674476
13.
Cytokine-induced immune complex binding to the high-affinity IgG receptor, FcγRI, in the presence of monomeric IgG.
Blood
; 116(24): 5327-33, 2010 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-20805361
14.
Human IgG2 antibodies against epidermal growth factor receptor effectively trigger antibody-dependent cellular cytotoxicity but, in contrast to IgG1, only by cells of myeloid lineage.
J Immunol
; 184(1): 512-20, 2010 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19949082
15.
Complement-mediated tumor-specific cell lysis by antibody combinations targeting epidermal growth factor receptor (EGFR) and its variant III (EGFRvIII).
Cancer Sci
; 102(10): 1761-8, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21718386
16.
c-Jun activating binding protein 1 binds to the IgA receptor and modulates protein levels of FcalphaRI and FcRgamma-chain.
Eur J Immunol
; 40(7): 2035-40, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20411563
17.
The in vivo mechanism of action of CD20 monoclonal antibodies depends on local tumor burden.
Haematologica
; 96(12): 1822-30, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21880632
18.
Binding of submaximal C1q promotes complement-dependent cytotoxicity (CDC) of B cells opsonized with anti-CD20 mAbs ofatumumab (OFA) or rituximab (RTX): considerably higher levels of CDC are induced by OFA than by RTX.
J Immunol
; 183(1): 749-58, 2009 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19535640
19.
The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.
Proc Natl Acad Sci U S A
; 105(16): 6109-14, 2008 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-18427122
20.
Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells.
Blood
; 112(6): 2390-9, 2008 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18566325